Video from ECR 2017: Dr. Johannes Heverhagen on gadolinium contrast

March 2, 2017

VIENNA - Gadolinium phobia remains a very real danger in Europe, but practical measures can help to reduce the risk, according to Dr. Johannes Heverhagen, PhD, professor and head of radiology at the University Hospital of Bern in Switzerland. In advance of Friday's ECR special focus session on the safety of gadolinium contrast agents for MRI, he also provides an update on the European Medicines Agency's investigation, the results of which are expected soon.

Vi deo loading ...
Dr. Johannes Heverhagen discusses gadolinium contrast agents for MRI.

Video produced by Christof. G. Pelz I GRAFIFANT Creation. Grafik. Photo I www.grafifant.at

Group calls for global research effort into gadolinium
Two European researchers are forging ahead with their proposal to collect clinical experiences and outcomes with gadolinium-based contrast agents (GBCAs)...
Video from RSNA 2016: Safety issues with gadolinium MRI contrast
CHICAGO - MRI safety has never been a hotter topic, particularly with respect to gadolinium contrast retention in the brain. Dr. Emanuel Kanal of the...
Study finds gadolinium hot spots, but no clinical effects
Patients who received more than 35 injections of gadolinium-based contrast agents had higher levels of signal intensity on unenhanced MR images of the...
New study adds to concerns about gadolinium deposition
A new study has found that deposition of gadolinium from MRI contrast in brain and bone tissue could be more common than previously thought. Researchers...
Danger of 'gadolinium phobia' looms in Europe
VIENNA - There's a serious risk of a phobia developing over the use of gadolinium-based MRI contrast agents, following the recent publication of a stinging...

Copyright © 2017 AuntMinnie.com

Last Updated np 3/13/2017 10:14:59 AM